60¢sixtycents

Takeda Pharmaceutical Company LimitedTAK

Is TAK cheap right now? Every multiple below is scored against its own 10-year range, not a sector average.

$20.27-0.16 (-0.78%)24:00 UTC
NYSEHealthcare

Company snapshot

Market Cap
$65B
Large-cap
+59%
2016 — today
10-Year Price
-22%
2016 — today
52-Week Range
$13.23$20.43
Current $20.27· 98%

Takeda Pharmaceutical, established in 1781 and based in Tokyo, is a global biopharmaceutical firm focused on the discovery, development, and commercialization of medicines. Its portfolio targets gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience, featuring brands like Entyvio, Takhzyro, and Vyvanse. Takeda maintains a vast international footprint and drives innovation through extensive strategic partnerships and licensing agreements with numerous research institutions and biotech firms.

Similar companies

Healthcare companies of comparable size to TAK
CompanyP/EDiv yield
BSXBoston Scientific Corporation18.3—
CORCencora, Inc.24.20.7%
NTRANatera, Inc.-302.1—
CAHCardinal Health, Inc.34.10.8%
ARGXargenx SE21.8—
CICigna Corporation12.32.1%
BDXBecton, Dickinson and Company58.72.0%
EWEdwards Lifesciences Corporation52.2—

Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.

Valuation in context

P/E ratio
56.6
Historically pricey
Historically pricey — last 10 years
Sector median 24.2above sector
P/B ratio
1.4
Above average
Pricier than usual over the last 10 years
Sector median 2.2below sector
EV / EBITDA
11.4
Above average
Pricier than usual over the last 10 years
Sector median 15.1below sector
Dividend Yield
3.4%
Historically low
Historically low relative to the last 10 years
Sector median 1.7%above sector
FCF Yield
5.5%
Below average
Below the 10-year average
Sector median -12.9%above sector
Free · No credit card needed

Get alerted when TAK is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.